Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Twelve-Month Outcomes of Standalone iStent Infinite in Primary Open-Angle Glaucoma.
Journal: Journal of clinical medicine
Published: April 25, 2026
Twelve-Month Outcomes of Standalone Travoprost Intracameral Implant in Glaucoma or Ocular Hypertension.
Journal: Life (Basel, Switzerland)
Published: February 17, 2026
Third-Generation Trabecular Micro-Bypass Implantation and Phacoemulsification in Patients with Glaucoma: A Multicenter Study.
Journal: Vision (Basel, Switzerland)
Published: June 03, 2025
Ten-Year Effectiveness and Safety of Trabecular Micro-Bypass Stent Implantation with Cataract Surgery in Patients with Glaucoma or Ocular Hypertension.
Journal: Ophthalmology and therapy
Published: April 16, 2024
Rates of visual field change and functional progression in glaucoma following trabecular microbypass implantation of iStent technologies: a meta-analysis.
Journal: BMJ open ophthalmology
Published: November 12, 2023
Effectiveness and Safety of iStent Infinite Trabecular Micro-Bypass for Uncontrolled Glaucoma.
Journal: Journal of glaucoma
Published: June 13, 2022
Treatment Success Across Different Levels of Preoperative Disease Burden: Stratified Two-Year Outcomes from the Pivotal Trial of iStent inject ® Trabecular Micro-Bypass in Primary Open-Angle Glaucoma and Cataract.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: April 21, 2021
Prospective, Randomized, Controlled Pivotal Trial of an Ab Interno Implanted Trabecular Micro-Bypass in Primary Open-Angle Glaucoma and Cataract: Two-Year Results.
Journal: Ophthalmology
Published: July 27, 2018
Long-term effectiveness and safety of trabecular microbypass stent implantation with cataract surgery in patients with glaucoma or ocular hypertension: Five-year outcomes.
Journal: Journal of cataract and refractive surgery
Published: March 15, 2018
Long-term titrated IOP control with one, two, or three trabecular micro-bypass stents in open-angle glaucoma subjects on topical hypotensive medication: 42-month outcomes.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: February 15, 2018
Prospective Evaluation of Two iStent® Trabecular Stents, One iStent Supra® Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year Outcomes.
Journal: Advances in therapy
Published: November 02, 2017
Efficacy of two trabecular micro-bypass stents combined with topical travoprost in open-angle glaucoma not controlled on two preoperative medications: 3-year follow-up.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: March 30, 2017
Last Updated: 09/26/2026